On Tuesday, HCA Healthcare Inc. HCA reported third-quarter revenues of $17.49 billion, up 7.9% year-over-year, slightly missing the consensus of $17.54 billion.

周二，HCA Healthcare Inc.HCA公布第三季度收入为174.9亿美元，同比增长7.9%，略低于175.4亿美元的共识。

The hospital chain reported adjusted EPS of $4.90, up from $3.91 a year ago, missing the consensus of $4.96.

这家连锁医院报告调整后的每股收益为4.90美元，高于一年前的3.91美元，低于普遍认为的4.96美元。

In the third quarter of 2024, same-facility admissions increased 4.5% year over year, while same-facility equivalent admissions increased 4.5%.

2024年第三季度，同一设施的入学人数同比增长4.5%，而同一设施的同等入学人数同比增长4.5%。

Same-facility emergency room visits increased by 4.6%, same-facility inpatient surgeries increased by 1.6%, and same-facility outpatient surgeries declined by 2.0%.

同一设施的急诊室就诊人数增加了4.6%，同一设施的住院手术增加了1.6%，同一设施的门诊手术减少了2.0%。

Same facility revenue per equivalent admission increased by 2.5%.

。

For the third quarter of 2024, adjusted EBITDA totaled $3.27 billion, compared to $2.88 billion a year ago.

2024年第三季度，调整后的息税折旧摊销前利润总额为32.7亿美元，而去年同期为28.8亿美元。

Guidance: HCA Healthcare reaffirmed its 2024 estimated guidance ranges. Given the ongoing impact of the two major hurricanes on the remainder of the year, the company estimates that results will likely be in the lower half of the ranges provided.

指导：HCA Healthcare重申了其2024年的估计指导范围。考虑到这两次主要飓风对今年剩余时间的持续影响，该公司估计结果可能会在所提供范围的下半部分。

During its second-quarter earnings release, the company revised its fiscal year 2024 revenue guidance to $69.75 billion—$71.75 billion, compared to prior guidance of $67.75 billion—$70.25 billion and the consensus of $70.91 billion.

在第二季度财报发布期间，该公司将2024财年的收入指导修改为697.5亿美元至717.5亿美元，而之前的指导为677.5亿美元至702.5亿美元，共识为709.1亿美元。

The company forecasts 2024 EPS guidance of $21.60-22.80, up from the prior guidance of $19.70-$21.20 and the consensus of $22.62.

该公司预测2024年每股收益指导值为21.60-22.80美元，高于之前的指导值19.70-21.20美元和共识值22.62美元。

The company expects 2024 adjusted EBITDA of $12.85 billion—$13.55 billion, versus the prior guidance of $13.75 billion—$14.25 billion.

该公司预计2024年调整后的息税折旧摊销前利润为128.5亿美元至135.5亿美元，而之前的指导为137.5亿美元至142.5亿美元。

During the fourth quarter of 2024, the company anticipates ongoing additional expenses and revenue losses due to Hurricane Helene's impact on its North Carolina facilities and Hurricane Milton, which impacted certain facilities in Florida during October, of approximately $200 to $300 million, or $0.60 to $0.90 per diluted share..

2024年第四季度，公司预计飓风海琳（Helene）对其北卡罗莱纳州设施的影响以及飓风米尔顿（Milton）对佛罗里达州某些设施的影响将导致持续的额外费用和收入损失，约为2亿至3亿美元，或稀释后每股0.60至0.90美元。。

HCA Healthcare anticipates some ongoing impact in 2025 from Hurricane Helene on its North Carolina facilities.

HCA Healthcare预计2025年飓风Helene将对其北卡罗莱纳州的设施产生持续影响。

The company believes these ongoing effects will be manageable and expects 2025 diluted EPS and Adjusted EBITDA growth to be near or slightly above the upper end of its long-term growth ranges.

该公司认为这些持续影响将是可控的，预计2025年稀释每股收益和调整后息税折旧摊销前利润增长将接近或略高于其长期增长范围的上限。

Price Action: HCA Healthcare stock is down 8.95% at $363.19 during the premarket session at last check Friday.

价格走势：HCA Healthcare股价在周五最后一次检查的上市前交易中下跌8.95%至363.19美元。

Read Next:

阅读下一页：

Centene Says It Is Positioned To Capture Long-Term Growth In Government-Sponsored Healthcare, Lifts Annual Outlook

Centene表示，它的定位是捕捉政府资助的医疗保健的长期增长，提升年度前景

Photo via CompanyMarket News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

照片通过公司市场新闻和Benzinga API提供给您的数据©2024 Benzinga.com。Benzinga不提供投资建议。保留所有权利。